+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global Research Antibodies Market by Indication (Immunology, Infectious Diseases, Neurobiology), Operation (Drug Development, Genomics, Proteomics), Product, Source, Technology, Type, End User - Forecast 2024-2030- Product Image
Global Research Antibodies Market by Indication (Immunology, Infectious Diseases, Neurobiology), Operation (Drug Development, Genomics, Proteomics), Product, Source, Technology, Type, End User - Forecast 2024-2030- Product Image
Sale

Global Research Antibodies Market by Indication (Immunology, Infectious Diseases, Neurobiology), Operation (Drug Development, Genomics, Proteomics), Product, Source, Technology, Type, End User - Forecast 2024-2030

  • PDF Icon

    Report

  • 188 Pages
  • May 2024
  • Region: Global
  • 360iResearch™
  • ID: 4995279
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Research Antibodies Market size was estimated at USD 6.27 billion in 2023, USD 6.79 billion in 2024, and is expected to grow at a CAGR of 8.43% to reach USD 11.05 billion by 2030.

The market for research antibodies refers to the global industry that revolves around the production, distribution, and application of antibodies for scientific research purposes. Antibodies are proteins utilized by the immune system to recognize and balance foreign substances, such as bacteria and viruses. In the research context, antibodies can be used in multiple applications, such as western blotting, flow cytometry, immunoprecipitation, immunofluorescence, and ELISA. The end-use for these antibodies is typically found in pharmaceutical and biotechnology companies, academic and research institutes, and contract research organizations.

The broad application base provides a wide market scope, with demand driving the development of innovative and high-specific antibodies for diverse research needs. The growth of the research antibodies market is influenced by several factors, including the rising popularity of genomics and proteomics research, increasing clinical trials and approvals of research antibodies, and heightened investment in R&D by pharmaceutical and biotech firms. However, the research antibodies market faces certain challenges, such as the high cost of production and procurement of high-quality research antibodies, quality concerns associated with research antibodies, and tightening regulations regarding the use of animals in antibody production. On the other hand, the proliferation of personalized medicine and biomarkers, increasing investment and funding for novel drug development, and the shift from traditional polyclonal antibodies to recombinant antibodies present potential opportunities for the research antibodies market in the coming years.

Regional Insights

In the United States, there is a robust demand for high-quality research antibodies, primarily due to the presence of major pharmaceutical companies, a strong focus on R&D in biotechnology and life sciences, and significant government and private investment. The National Institutes of Health (NIH), a prominent funding body, has a continuing initiative to support biomedical research, which positively impacts the antibody market. Canada's market is characterized by a growing biotechnology industry and increased government funding in medical research.

In South America, the research antibodies market is evolving, with countries such as Brazil and Argentina spearheading regional demand due to improving healthcare systems, increased governmental and private support for research, and a rise in non-communicable diseases. EU countries exhibit a strong demand for research antibodies due to well-established pharmaceutical and biotech industries, alongside extensive academic research activities. However, stringent regulatory policies may impose limitations on the market's growth. Focus on innovation and sustainability within research practices remains a central trend in European countries, including Germany, the UK, and France. The research antibody market in the Middle East is evolving with increasing investment in healthcare and research infrastructure. Africa's research antibody market is relatively untapped, with significant potential for growth. The APAC region exhibits rapid market growth due to emerging economies, increased healthcare funding, and expanding research sectors. China's antibody market is rapidly growing, with significant investments in biopharmaceutical R&D and a flourishing generics industry. Japan has an established pharmaceutical sector with a tradition of innovation, making it a significant market for research antibodies. Japan is known for its high standards in research practices, leading customers to demand antibodies with high specificity and reproducibility. India presents a rapidly evolving market with a surge in biosimilar research and a burgeoning biotech industry.

Market Trends by Segment

  • Indication: Increasing preference for research antibodies in immunology to understand autoimmune diseases
  • End User: Expanding usage of research antibodies among pharmaceutical & biotechnology companies

Industry Insights

  • Market Dynamics
  • Market Disruption Analysis
  • Porter’s Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis
  • FPNV Positioning Matrix
  • Market Share Analysis
  • Strategy Analysis and Recommendations

Recent Developments

Danaher Completes Acquisition of Abcam

Danaher Corporation announced the completion of its acquisition of Abcam PLC, a research antibody provider. This strategic move integrates Abcam into Danaher's portfolio as an indirectly wholly-owned subsidiary and has prompted the suspension of Abcam's trading on the Nasdaq.

AbbVie and BigHat Biosciences Announce Research Collaboration to Leverage Artificial Intelligence and Machine Learning to Discover Next-Generation Therapeutic Antibodies

AbbVie Inc. announced a strategic partnership with BigHat Biosciences to advance the discovery and development of innovative therapeutic antibodies within oncology and neuroscience. This initiative aligns with AbbVie’s goal to expedite the delivery of superior medicines by embracing AI/ML methodologies in its research.

AbCellera and Canada to invest $500M+ to boost antibody manufacturing and research

AbCellera Biologics Inc. secured a substantial investment from the Canadian federal government and the provincial government of British Columbia with USD 515.9 million. This strategic financial commitment is expected to facilitate AbCellera’s construction of state-of-the-art infrastructure dedicated to innovating and producing cutting-edge antibody therapeutics.

Key Company Profiles

The report delves into recent significant developments in the Research Antibodies Market, highlighting leading vendors and their innovative profiles. These include Abcam PLC, Absolute Antibody Ltd., Agilent Technologies, Inc., AvantGen, Inc., Becton, Dickinson and Company, Bio X Cell, Bio-Rad Laboratories, Inc., Bio-Techne Corporation, Cell Signaling Technology, Inc., Danaher Corporation, Enzo Life Sciences, Inc., F. Hoffmann-La Roche AG, GenScript Corporation, Jackson ImmunoResearch Inc., Merck KGaA, PerkinElmer, Inc., PROGEN Biotechnik GmbH, Proteintech Group, Inc., QIAGEN N.V., Santa Cruz Biotechnology Inc., Synaptic Systems GmbH, Sysmex Corporation, and Thermo Fisher Scientific Inc.

This research report offers invaluable insights into various crucial aspects of the Research Antibodies Market:

  1. Market Penetration: This section thoroughly overviews the current market landscape, incorporating detailed data from key industry players.
  2. Market Development: The report examines potential growth prospects in emerging markets and assesses expansion opportunities in mature segments.
  3. Market Diversification: This includes detailed information on recent product launches, untapped geographic regions, recent industry developments, and strategic investments.
  4. Competitive Assessment & Intelligence: An in-depth analysis of the competitive landscape is conducted, covering market share, strategic approaches, product range, certifications, regulatory approvals, patent analysis, technology developments, and advancements in the manufacturing capabilities of leading market players.
  5. Product Development & Innovation: This section offers insights into upcoming technologies, research and development efforts, and notable advancements in product innovation.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current market size and projected growth?
  2. Which products, segments, applications, and regions offer promising investment opportunities?
  3. What are the prevailing technology trends and regulatory frameworks?
  4. What is the market share and positioning of the leading vendors?
  5. What revenue sources and strategic opportunities do vendors in the market consider when deciding to enter or exit?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising Popularity of Genomics and Proteomics Research
5.1.1.2. Increasing Clinical Trials and Approvals of Research Antibodies
5.1.2. Restraints
5.1.2.1. Time and Cost Consuming Antibody Development Processes
5.1.3. Opportunities
5.1.3.1. Proliferation of Personalized Medicine and Biomarkers
5.1.3.2. Increasing Investment and Funding for Novel Drug Development
5.1.4. Challenges
5.1.4.1. Quality Concerns Associated with Research Antibodies
5.2. Market Segmentation Analysis
5.2.1. Indication: Increasing preference for research antibodies in immunology to understand autoimmune diseases
5.2.2. End User: Expanding usage of research antibodies among pharmaceutical & biotechnology companies
5.3. Market Trend Analysis
5.4. Cumulative Impact of Russia-Ukraine Conflict
5.5. Cumulative Impact of High Inflation
5.6. Porter’s Five Forces Analysis
5.6.1. Threat of New Entrants
5.6.2. Threat of Substitutes
5.6.3. Bargaining Power of Customers
5.6.4. Bargaining Power of Suppliers
5.6.5. Industry Rivalry
5.7. Value Chain & Critical Path Analysis
5.8. Regulatory Framework Analysis
5.9. Client Customization
6. Research Antibodies Market, by Indication
6.1. Introduction
6.2. Immunology
6.3. Infectious Diseases
6.4. Neurobiology
6.5. Oncology
6.6. Stem Cells
7. Research Antibodies Market, by Operation
7.1. Introduction
7.2. Drug Development
7.3. Genomics
7.4. Proteomics
8. Research Antibodies Market, by Product
8.1. Introduction
8.2. Monoclonal Antibodies
8.3. Polyclonal Antibodies
9. Research Antibodies Market, by Source
9.1. Introduction
9.2. Goat
9.3. Mouse
9.4. Rabbit
10. Research Antibodies Market, by Technology
10.1. Introduction
10.2. Enzyme-Linked Immunosorbent Assay
10.3. Flow Cytometry
10.4. Immunofluorescence
10.5. Immunohistochemistry
10.6. Immunoprecipitation
10.7. Western Blotting
11. Research Antibodies Market, by Type
11.1. Introduction
11.2. Primary Antibodies
11.3. Secondary Antibodies
12. Research Antibodies Market, by End User
12.1. Introduction
12.2. Academic & Research Institutes
12.3. Pharmaceutical & Biotechnology Companies
13. Americas Research Antibodies Market
13.1. Introduction
13.2. Argentina
13.3. Brazil
13.4. Canada
13.5. Mexico
13.6. United States
14. Asia-Pacific Research Antibodies Market
14.1. Introduction
14.2. Australia
14.3. China
14.4. India
14.5. Indonesia
14.6. Japan
14.7. Malaysia
14.8. Philippines
14.9. Singapore
14.10. South Korea
14.11. Taiwan
14.12. Thailand
14.13. Vietnam
15. Europe, Middle East & Africa Research Antibodies Market
15.1. Introduction
15.2. Denmark
15.3. Egypt
15.4. Finland
15.5. France
15.6. Germany
15.7. Israel
15.8. Italy
15.9. Netherlands
15.10. Nigeria
15.11. Norway
15.12. Poland
15.13. Qatar
15.14. Russia
15.15. Saudi Arabia
15.16. South Africa
15.17. Spain
15.18. Sweden
15.19. Switzerland
15.20. Turkey
15.21. United Arab Emirates
15.22. United Kingdom
16. Competitive Landscape
16.1. Market Share Analysis, 2023
16.2. FPNV Positioning Matrix, 2023
16.3. Competitive Scenario Analysis
16.3.1. Danaher Completes Acquisition of Abcam
16.3.2. AbbVie and BigHat Biosciences Announce Research Collaboration to Leverage Artificial Intelligence and Machine Learning to Discover Next-Generation Therapeutic Antibodies
16.3.3. AbCellera and Canada to invest $500M+ to boost antibody manufacturing and research
17. Competitive Portfolio
17.1. Key Company Profiles
17.2. Key Product Portfolio
List of Figures
FIGURE 1. RESEARCH ANTIBODIES MARKET RESEARCH PROCESS
FIGURE 2. RESEARCH ANTIBODIES MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. RESEARCH ANTIBODIES MARKET DYNAMICS
FIGURE 7. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
FIGURE 8. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2023 VS 2030 (%)
FIGURE 10. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 12. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2023 VS 2030 (%)
FIGURE 14. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
FIGURE 16. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 18. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2023 VS 2030 (%)
FIGURE 20. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. AMERICAS RESEARCH ANTIBODIES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. AMERICAS RESEARCH ANTIBODIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. UNITED STATES RESEARCH ANTIBODIES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 24. UNITED STATES RESEARCH ANTIBODIES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC RESEARCH ANTIBODIES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC RESEARCH ANTIBODIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 27. EUROPE, MIDDLE EAST & AFRICA RESEARCH ANTIBODIES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 28. EUROPE, MIDDLE EAST & AFRICA RESEARCH ANTIBODIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 29. RESEARCH ANTIBODIES MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 30. RESEARCH ANTIBODIES MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. RESEARCH ANTIBODIES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY NEUROBIOLOGY, BY REGION, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY NEUROBIOLOGY, BY REGION, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY ONCOLOGY, BY REGION, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY STEM CELLS, BY REGION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY STEM CELLS, BY REGION, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY DRUG DEVELOPMENT, BY REGION, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY DRUG DEVELOPMENT, BY REGION, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY GENOMICS, BY REGION, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY GENOMICS, BY REGION, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY PROTEOMICS, BY REGION, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY PROTEOMICS, BY REGION, 2024-2030 (USD MILLION)
TABLE 27. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 28. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 29. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 30. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 31. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY POLYCLONAL ANTIBODIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 32. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY POLYCLONAL ANTIBODIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 33. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 34. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 35. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY GOAT, BY REGION, 2018-2023 (USD MILLION)
TABLE 36. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY GOAT, BY REGION, 2024-2030 (USD MILLION)
TABLE 37. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY MOUSE, BY REGION, 2018-2023 (USD MILLION)
TABLE 38. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY MOUSE, BY REGION, 2024-2030 (USD MILLION)
TABLE 39. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY RABBIT, BY REGION, 2018-2023 (USD MILLION)
TABLE 40. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY RABBIT, BY REGION, 2024-2030 (USD MILLION)
TABLE 41. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 42. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 43. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY ENZYME-LINKED IMMUNOSORBENT ASSAY, BY REGION, 2018-2023 (USD MILLION)
TABLE 44. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY ENZYME-LINKED IMMUNOSORBENT ASSAY, BY REGION, 2024-2030 (USD MILLION)
TABLE 45. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2018-2023 (USD MILLION)
TABLE 46. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2024-2030 (USD MILLION)
TABLE 47. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY IMMUNOFLUORESCENCE, BY REGION, 2018-2023 (USD MILLION)
TABLE 48. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY IMMUNOFLUORESCENCE, BY REGION, 2024-2030 (USD MILLION)
TABLE 49. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, BY REGION, 2018-2023 (USD MILLION)
TABLE 50. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, BY REGION, 2024-2030 (USD MILLION)
TABLE 51. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY IMMUNOPRECIPITATION, BY REGION, 2018-2023 (USD MILLION)
TABLE 52. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY IMMUNOPRECIPITATION, BY REGION, 2024-2030 (USD MILLION)
TABLE 53. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY WESTERN BLOTTING, BY REGION, 2018-2023 (USD MILLION)
TABLE 54. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY WESTERN BLOTTING, BY REGION, 2024-2030 (USD MILLION)
TABLE 55. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 56. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 57. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY PRIMARY ANTIBODIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 58. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY PRIMARY ANTIBODIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 59. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY SECONDARY ANTIBODIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 60. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY SECONDARY ANTIBODIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 61. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 62. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 63. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2023 (USD MILLION)
TABLE 64. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024-2030 (USD MILLION)
TABLE 65. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 66. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 67. AMERICAS RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 68. AMERICAS RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 69. AMERICAS RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2018-2023 (USD MILLION)
TABLE 70. AMERICAS RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2024-2030 (USD MILLION)
TABLE 71. AMERICAS RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 72. AMERICAS RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 73. AMERICAS RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 74. AMERICAS RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 75. AMERICAS RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 76. AMERICAS RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 77. AMERICAS RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 78. AMERICAS RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 79. AMERICAS RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 80. AMERICAS RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 81. AMERICAS RESEARCH ANTIBODIES MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 82. AMERICAS RESEARCH ANTIBODIES MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 83. ARGENTINA RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 84. ARGENTINA RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 85. ARGENTINA RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2018-2023 (USD MILLION)
TABLE 86. ARGENTINA RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2024-2030 (USD MILLION)
TABLE 87. ARGENTINA RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 88. ARGENTINA RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 89. ARGENTINA RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 90. ARGENTINA RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 91. ARGENTINA RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 92. ARGENTINA RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 93. ARGENTINA RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 94. ARGENTINA RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 95. ARGENTINA RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 96. ARGENTINA RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 97. BRAZIL RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 98. BRAZIL RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 99. BRAZIL RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2018-2023 (USD MILLION)
TABLE 100. BRAZIL RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2024-2030 (USD MILLION)
TABLE 101. BRAZIL RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 102. BRAZIL RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 103. BRAZIL RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 104. BRAZIL RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 105. BRAZIL RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 106. BRAZIL RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 107. BRAZIL RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 108. BRAZIL RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 109. BRAZIL RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 110. BRAZIL RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 111. CANADA RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 112. CANADA RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 113. CANADA RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2018-2023 (USD MILLION)
TABLE 114. CANADA RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2024-2030 (USD MILLION)
TABLE 115. CANADA RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 116. CANADA RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 117. CANADA RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 118. CANADA RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 119. CANADA RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 120. CANADA RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 121. CANADA RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 122. CANADA RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 123. CANADA RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 124. CANADA RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 125. MEXICO RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 126. MEXICO RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 127. MEXICO RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2018-2023 (USD MILLION)
TABLE 128. MEXICO RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2024-2030 (USD MILLION)
TABLE 129. MEXICO RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 130. MEXICO RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 131. MEXICO RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 132. MEXICO RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 133. MEXICO RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 134. MEXICO RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 135. MEXICO RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 136. MEXICO RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 137. MEXICO RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 138. MEXICO RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 139. UNITED STATES RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 140. UNITED STATES RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 141. UNITED STATES RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2018-2023 (USD MILLION)
TABLE 142. UNITED STATES RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2024-2030 (USD MILLION)
TABLE 143. UNITED STATES RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 144. UNITED STATES RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 145. UNITED STATES RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 146. UNITED STATES RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 147. UNITED STATES RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 148. UNITED STATES RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 149. UNITED STATES RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 150. UNITED STATES RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 151. UNITED STATES RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 152. UNITED STATES RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 153. UNITED STATES RESEARCH ANTIBODIES MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 154. UNITED STATES RESEARCH ANTIBODIES MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 155. ASIA-PACIFIC RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 156. ASIA-PACIFIC RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 157. ASIA-PACIFIC RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2018-2023 (USD MILLION)
TABLE 158. ASIA-PACIFIC RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2024-2030 (USD MILLION)
TABLE 159. ASIA-PACIFIC RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 160. ASIA-PACIFIC RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 161. ASIA-PACIFIC RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 162. ASIA-PACIFIC RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 163. ASIA-PACIFIC RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 164. ASIA-PACIFIC RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 165. ASIA-PACIFIC RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 166. ASIA-PACIFIC RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 167. ASIA-PACIFIC RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 168. ASIA-PACIFIC RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 169. ASIA-PACIFIC RESEARCH ANTIBODIES MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 170. ASIA-PACIFIC RESEARCH ANTIBODIES MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 171. AUSTRALIA RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 172. AUSTRALIA RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 173. AUSTRALIA RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2018-2023 (USD MILLION)
TABLE 174. AUSTRALIA RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2024-2030 (USD MILLION)
TABLE 175. AUSTRALIA RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 176. AUSTRALIA RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 177. AUSTRALIA RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 178. AUSTRALIA RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 179. AUSTRALIA RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 180. AUSTRALIA RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 181. AUSTRALIA RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 182. AUSTRALIA RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 183. AUSTRALIA RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 184. AUSTRALIA RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 185. CHINA RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 186. CHINA RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 187. CHINA RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2018-2023 (USD MILLION)
TABLE 188. CHINA RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2024-2030 (USD MILLION)
TABLE 189. CHINA RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 190. CHINA RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 191. CHINA RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 192. CHINA RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 193. CHINA RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 194. CHINA RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 195. CHINA RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 196. CHINA RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 197. CHINA RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 198. CHINA RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 199. INDIA RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 200. INDIA RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 201. INDIA RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2018-2023 (USD MILLION)
TABLE 202. INDIA RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2024-2030 (USD MILLION)
TABLE 203. INDIA RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 204. INDIA RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 205. INDIA RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 206. INDIA RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 207. INDIA RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 208. INDIA RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 209. INDIA RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 210. INDIA RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 211. INDIA RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 212. INDIA RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 213. INDONESIA RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 214. INDONESIA RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 215. INDONESIA RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2018-2023 (USD MILLION)
TABLE 216. INDONESIA RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2024-2030 (USD MILLION)
TABLE 217. INDONESIA RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 218. INDONESIA RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 219. INDONESIA RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 220. INDONESIA RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 221. INDONESIA RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 222. INDONESIA RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 223. INDONESIA RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 224. INDONESIA RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 225. INDONESIA RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 226. INDONESIA RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 227. JAPAN RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 228. JAPAN RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 229. JAPAN RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2018-2023 (USD MILLION)
TABLE 230. JAPAN RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2024-2030 (USD MILLION)
TABLE 231. JAPAN RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 232. JAPAN RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 233. JAPAN RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 234. JAPAN RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 235. JAPAN RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 236. JAPAN RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 237. JAPAN RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 238. JAPAN RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 239. JAPAN RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 240. JAPAN RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 241. MALAYSIA RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 242. MALAYSIA RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 243. MALAYSIA RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2018-2023 (USD MILLION)
TABLE 244. MALAYSIA RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2024-2030 (USD MILLION)
TABLE 245. MALAYSIA RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 246. MALAYSIA RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 247. MALAYSIA RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 248. MALAYSIA RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 249. MALAYSIA RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 250. MALAYSIA RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 251. MALAYSIA RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 252. MALAYSIA RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 253. MALAYSIA RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 254. MALAYSIA RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 255. PHILIPPINES RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 256. PHILIPPINES RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 257. PHILIPPINES RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2018-2023 (USD MILLION)
TABLE 258. PHILIPPINES RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2024-2030 (USD MILLION)
TABLE 259. PHILIPPINES RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 260. PHILIPPINES RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 261. PHILIPPINES RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 262. PHILIPPINES RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 263. PHILIPPINES RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 264. PHILIPPINES RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 265. PHILIPPINES RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 266. PHILIPPINES RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 267. PHILIPPINES RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 268. PHILIPPINES RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 269. SINGAPORE RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 270. SINGAPORE RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 271. SINGAPORE RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2018-2023 (USD MILLION)
TABLE 272. SINGAPORE RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2024-2030 (USD MILLION)
TABLE 273. SINGAPORE RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 274. SINGAPORE RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 275. SINGAPORE RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 276. SINGAPORE RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 277. SINGAPORE RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 278. SINGAPORE RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 279. SINGAPORE RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 280. SINGAPORE RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 281. SINGAPORE RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 282. SINGAPORE RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 283. SOUTH KOREA RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 284. SOUTH KOREA RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 285. SOUTH KOREA RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2018-2023 (USD MILLION)
TABLE 286. SOUTH KOREA RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2024-2030 (USD MILLION)
TABLE 287. SOUTH KOREA RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 288. SOUTH KOREA RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 289. SOUTH KOREA RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 290. SOUTH KOREA RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 291. SOUTH KOREA RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 292. SOUTH KOREA RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 293. SOUTH KOREA RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 294. SOUTH KOREA RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 295. SOUTH KOREA RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 296. SOUTH KOREA RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 297. TAIWAN RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 298. TAIWAN RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 299. TAIWAN RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2018-2023 (USD MILLION)
TABLE 300. TAIWAN RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2024-2030 (USD MILLION)
TABLE 301. TAIWAN RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 302. TAIWAN RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 303. TAIWAN RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 304. TAIWAN RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 305. TAIWAN RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 306. TAIWAN RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 307. TAIWAN RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 308. TAIWAN RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 309. TAIWAN RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 310. TAIWAN RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 311. THAILAND RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 312. THAILAND RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 313. THAILAND RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2018-2023 (USD MILLION)
TABLE 314. THAILAND RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2024-2030 (USD MILLION)
TABLE 315. THAILAND RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 316. THAILAND RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 317. THAILAND RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 318. THAILAND RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 319. THAILAND RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 320. THAILAND RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 321. THAILAND RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 322. THAILAND RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 323. THAILAND RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 324. THAILAND RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 325. VIETNAM RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 326. VIETNAM RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 327. VIETNAM RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2018-2023 (USD MILLION)
TABLE 328. VIETNAM RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2024-2030 (USD MILLION)
TABLE 329. VIETNAM RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 330. VIETNAM RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 331. VIETNAM RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 332. VIETNAM RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 333. VIETNAM RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 334. VIETNAM RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 335. VIETNAM RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 336. VIETNAM RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 337. VIETNAM RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 338. VIETNAM RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 339. EUROPE, MIDDLE EAST & AFRICA RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 340. EUROPE, MIDDLE EAST & AFRICA RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 341. EUROPE, MIDDLE EAST & AFRICA RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2018-2023 (USD MILLION)
TABLE 342. EUROPE, MIDDLE EAST & AFRICA RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2024-2030 (USD MILLION)
TABLE 343. EUROPE, MIDDLE EAST & AFRICA RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 344. EUROPE, MIDDLE EAST & AFRICA RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 345. EUROPE, MIDDLE EAST & AFRICA RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 346. EUROPE, MIDDLE EAST & AFRICA RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 347. EUROPE, MIDDLE EAST & AFRICA RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 348. EUROPE, MIDDLE EAST & AFRICA RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 349. EUROPE, MIDDLE EAST & AFRICA RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 350. EUROPE, MIDDLE EAST & AFRICA RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 351. EUROPE, MIDDLE EAST & AFRICA RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 352. EUROPE, MIDDLE EAST & AFRICA RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 353. EUROPE, MIDDLE EAST & AFRICA RESEARCH ANTIBODIES MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 354. EUROPE, MIDDLE EAST & AFRICA RESEARCH ANTIBODIES MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 355. DENMARK RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2018-2023 (USD

Companies Mentioned

  • Abcam PLC
  • Absolute Antibody Ltd.
  • Agilent Technologies, Inc.
  • AvantGen, Inc.
  • Becton, Dickinson and Company
  • Bio X Cell
  • Bio-Rad Laboratories, Inc.
  • Bio-Techne Corporation
  • Cell Signaling Technology, Inc.
  • Danaher Corporation
  • Enzo Life Sciences, Inc.
  • F. Hoffmann-La Roche AG
  • GenScript Corporation
  • Jackson ImmunoResearch Inc.
  • Merck KGaA
  • PerkinElmer, Inc.
  • PROGEN Biotechnik GmbH
  • Proteintech Group, Inc.
  • QIAGEN N.V.
  • Santa Cruz Biotechnology Inc.
  • Synaptic Systems GmbH
  • Sysmex Corporation
  • Thermo Fisher Scientific Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages188
PublishedMay 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 6.79 Billion
Forecasted Market Value ( USD ) by 2030 $ 11.05 Billion
Compound Annual Growth Rate8.4%
Regions CoveredGlobal
No. of Companies Mentioned23

Related Topics

Related Reports

Global Monoclonal Antibodies Market by Source Type (Chimeric, Human, Humanized), Production Type (In Vitro, In Vivo), Indication, End-User - Forecast 2024-2030 - Product Image

Global Monoclonal Antibodies Market by Source Type (Chimeric, Human, Humanized), Production Type (In Vitro, In Vivo), Indication, End-User - Forecast 2024-2030

  • Report
  • 184 Pages
  • Global
From
Global Cancer Monoclonal Antibodies Market by Type (Chimeric, Human, Humanized), Application (Blood Cancer, Breast Cancer, Colorectal Cancer), End-user - Forecast 2024-2030 - Product Image

Global Cancer Monoclonal Antibodies Market by Type (Chimeric, Human, Humanized), Application (Blood Cancer, Breast Cancer, Colorectal Cancer), End-user - Forecast 2024-2030

  • Report
  • 188 Pages
  • Global
From
Bispecific Antibodies Market Size, Share & Trends Analysis Report By Indication (Cancer, Inflammatory & Autoimmune disorders), By Region (North America, Europe, Asia Pacific), And Segment Forecasts, 2023-2030 - Product Image

Bispecific Antibodies Market Size, Share & Trends Analysis Report By Indication (Cancer, Inflammatory & Autoimmune disorders), By Region (North America, Europe, Asia Pacific), And Segment Forecasts, 2023-2030

  • Report
  • 120 Pages
  • Global
From
Polyclonal Antibodies Market Size, Share & Trends Analysis Report By Product (Primary, Secondary), By Application (Biomedical Research, Diagnostics), By Source (Rabbit, Goats), By End-user, By Region, And Segment Forecasts, 2023 - 2030 - Product Image

Polyclonal Antibodies Market Size, Share & Trends Analysis Report By Product (Primary, Secondary), By Application (Biomedical Research, Diagnostics), By Source (Rabbit, Goats), By End-user, By Region, And Segment Forecasts, 2023 - 2030

  • Report
  • 110 Pages
  • Global
From
Research Antibodies & Reagents Market by Product (Antibodies (Type, Form, Source, Research Area), Reagents), Technology (Western blot, Flow Cytometry, ELISA), Application (Proteomics, Genomics), End User (Pharma, Biotech, CROs) & Region - Global forecast to 2028 - Product Image

Research Antibodies & Reagents Market by Product (Antibodies (Type, Form, Source, Research Area), Reagents), Technology (Western blot, Flow Cytometry, ELISA), Application (Proteomics, Genomics), End User (Pharma, Biotech, CROs) & Region - Global forecast to 2028

  • Report
  • 385 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.